1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Europe Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Segment
6.1 Unbranded Generics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Branded Generics
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Therapy Area
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genitourinary/Hormonal
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Rheumatology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Diabetes
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Oncology
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Drug Delivery
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Dermal/Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Inhalers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Country
10.1 Germany
10.1.1 Market Trends
10.1.2 Market Breakup by Segment
10.1.3 Market Breakup by Therapy Area
10.1.4 Market Breakup by Drug Delivery
10.1.5 Market Breakup by Distribution Channel
10.1.6 Market Forecast
10.2 France
10.2.1 Market Trends
10.2.2 Market Breakup by Segment
10.2.3 Market Breakup by Therapy Area
10.2.4 Market Breakup by Drug Delivery
10.2.5 Market Breakup by Distribution Channel
10.2.6 Market Forecast
10.3 United Kingdom
10.3.1 Market Trends
10.3.2 Market Breakup by Segment
10.3.3 Market Breakup by Therapy Area
10.3.4 Market Breakup by Drug Delivery
10.3.5 Market Breakup by Distribution Channel
10.3.6 Market Forecast
10.4 Italy
10.4.1 Market Trends
10.4.2 Market Breakup by Segment
10.4.3 Market Breakup by Therapy Area
10.4.4 Market Breakup by Drug Delivery
10.4.5 Market Breakup by Distribution Channel
10.4.6 Market Forecast
10.5 Spain
10.5.1 Market Trends
10.5.2 Market Breakup by Segment
10.5.3 Market Breakup by Therapy Area
10.5.4 Market Breakup by Drug Delivery
10.5.5 Market Breakup by Distribution Channel
10.5.6 Market Forecast
10.6 Others
10.6.1 Market Trends
10.6.2 Market Breakup by Segment
10.6.3 Market Breakup by Therapy Area
10.6.4 Market Breakup by Drug Delivery
10.6.5 Market Breakup by Distribution Channel
10.6.6 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Policy and Regulatory Landscape
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
List of Figures
Figure 1: Europe: Generic Drug Market: Major Drivers and Challenges
Figure 2: Europe: Generic Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Europe: Generic Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Europe: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 5: Europe: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 6: Europe: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 7: Europe: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Europe: Generic Drug Market: Breakup by Country (in %), 2023
Figure 9: Europe: Generic Drug (Unbranded Generics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Europe: Generic Drug (Unbranded Generics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Europe: Generic Drug (Branded Generics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Europe: Generic Drug (Branded Generics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Europe: Generic Drug (Central Nervous System) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Europe: Generic Drug (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Europe: Generic Drug (Cardiovascular) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Europe: Generic Drug (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Europe: Generic Drug (Dermatology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Europe: Generic Drug (Dermatology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Europe: Generic Drug (Genitourinary/Hormonal) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Europe: Generic Drug (Genitourinary/Hormonal) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Europe: Generic Drug (Respiratory) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Europe: Generic Drug (Respiratory) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Europe: Generic Drug (Rheumatology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Europe: Generic Drug (Rheumatology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Europe: Generic Drug (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Europe: Generic Drug (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Europe: Generic Drug (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Europe: Generic Drug (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Europe: Generic Drug (Other Therapy Areas) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Europe: Generic Drug (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Europe: Generic Drug (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Europe: Generic Drug (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Europe: Generic Drug (Injectables) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Europe: Generic Drug (Injectables) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Europe: Generic Drug (Dermal/Topical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Europe: Generic Drug (Dermal/Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Europe: Generic Drug (Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Europe: Generic Drug (Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Europe: Generic Drug (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Europe: Generic Drug (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Europe: Generic Drug (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Europe: Generic Drug (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Germany: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Germany: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 45: Germany: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 46: Germany: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 47: Germany: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 48: Germany: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: France: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: France: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 51: France: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 52: France: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 53: France: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 54: France: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: United Kingdom: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: United Kingdom: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 57: United Kingdom: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 58: United Kingdom: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 59: United Kingdom: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 60: United Kingdom: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Italy: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Italy: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 63: Italy: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 64: Italy: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 65: Italy: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 66: Italy: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Spain: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Spain: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 69: Spain: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 70: Spain: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 71: Spain: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 72: Spain: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Europe: Generic Drug Industry: SWOT Analysis
Figure 76: Europe: Generic Drug Industry: Value Chain Analysis
Figure 77: Europe: Generic Drug Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Europe: Generic Drug Market: Key Industry Highlights, 2023 and 2032
Table 2: Europe: Generic Drug Market Forecast: Breakup by Segment (in Million US$), 2024-2032
Table 3: Europe: Generic Drug Market Forecast: Breakup by Therapy Area (in Million US$), 2024-2032
Table 4: Europe: Generic Drug Market Forecast: Breakup by Drug Delivery (in Million US$), 2024-2032
Table 5: Europe: Generic Drug Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Europe: Generic Drug Market Forecast: Breakup by Country (in Million US$), 2024-2032
Table 7: Europe: Generic Drug Market: Competitive Structure
Table 8: Europe: Generic Drug Market: Key Players